HCA Healthcare Future Growth
Future criteria checks 2/6
HCA Healthcare is forecast to grow earnings and revenue by 6.4% and 5.2% per annum respectively. EPS is expected to grow by 10.7% per annum. Return on equity is forecast to be 121.2% in 3 years.
Key information
6.4%
Earnings growth rate
10.7%
EPS growth rate
Healthcare earnings growth | 17.6% |
Revenue growth rate | 5.2% |
Future return on equity | 121.2% |
Analyst coverage | Good |
Last updated | 31 Jan 2025 |
Recent future growth updates
Results: HCA Healthcare, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Jul 26HCA Healthcare, Inc. Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next
Apr 30HCA Healthcare, Inc. (NYSE:HCA) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 02Recent updates
HCA Healthcare's (NYSE:HCA) Dividend Will Be Increased To $0.72
Jan 27HCA Healthcare Q4 Earnings Recap: Overreaction To One-Time Event
Jan 24Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?
Jan 12HCA Healthcare: Sentiment Has Swung Too Negative
Dec 29We Think HCA Healthcare (NYSE:HCA) Can Stay On Top Of Its Debt
Dec 26Shareholders Would Enjoy A Repeat Of HCA Healthcare's (NYSE:HCA) Recent Growth In Returns
Nov 10HCA Healthcare Q3 Earnings Preview: Step Change In Value (Rating Upgrade)
Oct 22HCA Healthcare, Inc. (NYSE:HCA) Not Lagging Market On Growth Or Pricing
Oct 16HCA Healthcare, Inc.'s (NYSE:HCA) Intrinsic Value Is Potentially 63% Above Its Share Price
Oct 01HCA Healthcare: Still A Great Play On Long-Term Growth And Valuation
Sep 28Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?
Sep 16Does HCA Healthcare (NYSE:HCA) Have A Healthy Balance Sheet?
Sep 01Results: HCA Healthcare, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Jul 26Are Investors Undervaluing HCA Healthcare, Inc. (NYSE:HCA) By 27%?
Jun 21HCA Healthcare, Inc.'s (NYSE:HCA) P/E Still Appears To Be Reasonable
Jun 06Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?
May 21HCA Healthcare, Inc. Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next
Apr 30Capital Investment Trends At HCA Healthcare (NYSE:HCA) Look Strong
Apr 11HCA Healthcare Is Finally At Fair Value (Rating Downgrade)
Mar 19HCA Healthcare: Improving Margins Now Reflected In Shares (Rating Downgrade)
Feb 29HCA Healthcare (NYSE:HCA) Is Increasing Its Dividend To $0.66
Feb 25HCA Healthcare (NYSE:HCA) Is Paying Out A Larger Dividend Than Last Year
Feb 05HCA Healthcare, Inc. (NYSE:HCA) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 02HCA Healthcare Continues To Impress
Dec 14HCA Remains Attractive Despite A JV Misstep
Nov 20HCA Healthcare: Rx For Success
Oct 10HCA Healthcare: Impact Of Medicare Advantage Growth And Demographic Shift
Sep 30HCA Healthcare Is Beating The Industry
Sep 13HCA Healthcare's Service Optimization And Capabilities Support Long-Run Growth
Jul 03Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 82,798 | 6,983 | 6,060 | 12,029 | 10 |
12/31/2026 | 78,520 | 6,531 | 5,862 | 11,270 | 21 |
12/31/2025 | 74,635 | 6,128 | 5,939 | 10,948 | 21 |
12/31/2024 | 70,603 | 5,760 | 5,639 | 10,514 | N/A |
9/30/2024 | 69,621 | 5,929 | 5,880 | 10,629 | N/A |
6/30/2024 | 68,347 | 5,738 | 4,888 | 9,593 | N/A |
3/31/2024 | 66,716 | 5,470 | 5,432 | 10,097 | N/A |
12/31/2023 | 64,968 | 5,242 | 4,687 | 9,431 | N/A |
9/30/2023 | 63,162 | 5,716 | 4,376 | 9,284 | N/A |
6/30/2023 | 61,920 | 5,771 | 4,933 | 9,825 | N/A |
3/31/2023 | 60,879 | 5,733 | 4,249 | 8,980 | N/A |
12/31/2022 | 60,233 | 5,643 | 4,127 | 8,522 | N/A |
9/30/2022 | 59,800 | 5,376 | 4,174 | 8,438 | N/A |
6/30/2022 | 60,105 | 6,511 | 3,673 | 7,695 | N/A |
3/31/2022 | 59,720 | 6,806 | 4,532 | 8,316 | N/A |
12/31/2021 | 58,752 | 6,956 | 5,382 | 8,959 | N/A |
9/30/2021 | 57,981 | 6,568 | -200 | 2,933 | N/A |
6/30/2021 | 56,016 | 4,967 | 640 | 3,373 | N/A |
3/31/2021 | 52,649 | 4,596 | 7,209 | 9,845 | N/A |
12/31/2020 | 51,533 | 3,754 | 6,397 | 9,232 | N/A |
9/30/2020 | 50,763 | 3,399 | 11,959 | 15,320 | N/A |
6/30/2020 | 50,146 | 3,343 | 10,718 | 14,729 | N/A |
3/31/2020 | 51,680 | 3,047 | 3,773 | 8,003 | N/A |
12/31/2019 | 51,336 | 3,505 | 3,444 | 7,602 | N/A |
9/30/2019 | 50,087 | 3,498 | 3,235 | 7,272 | N/A |
6/30/2019 | 48,844 | 3,645 | 3,123 | 6,867 | N/A |
3/31/2019 | 47,771 | 3,682 | 2,792 | 6,452 | N/A |
12/31/2018 | 46,677 | 3,787 | 3,188 | 6,761 | N/A |
9/30/2018 | 45,965 | 3,197 | N/A | 6,320 | N/A |
6/30/2018 | 45,210 | 2,864 | N/A | 5,607 | N/A |
3/31/2018 | 44,414 | 2,701 | N/A | 5,429 | N/A |
12/31/2017 | 43,614 | 2,216 | N/A | 5,426 | N/A |
9/30/2017 | 42,693 | 2,662 | N/A | 5,391 | N/A |
6/30/2017 | 42,267 | 2,854 | N/A | 5,589 | N/A |
3/31/2017 | 41,853 | 2,855 | N/A | 5,534 | N/A |
12/31/2016 | 41,490 | 2,890 | N/A | 5,653 | N/A |
9/30/2016 | 41,098 | 2,552 | N/A | 5,512 | N/A |
6/30/2016 | 40,684 | 2,383 | N/A | 5,407 | N/A |
3/31/2016 | 40,262 | 2,232 | N/A | 5,115 | N/A |
12/31/2015 | 39,678 | 2,129 | N/A | 4,734 | N/A |
9/30/2015 | 39,065 | 2,074 | N/A | 4,803 | N/A |
6/30/2015 | 38,429 | 2,143 | N/A | 4,830 | N/A |
3/31/2015 | 37,762 | 2,119 | N/A | 5,023 | N/A |
12/31/2014 | 36,918 | 1,875 | N/A | 4,448 | N/A |
9/30/2014 | 36,118 | 1,772 | N/A | 4,047 | N/A |
6/30/2014 | 35,354 | 1,619 | N/A | 3,819 | N/A |
3/31/2014 | 34,574 | 1,559 | N/A | 3,383 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HCA's forecast earnings growth (6.4% per year) is above the savings rate (2.6%).
Earnings vs Market: HCA's earnings (6.4% per year) are forecast to grow slower than the US market (15.1% per year).
High Growth Earnings: HCA's earnings are forecast to grow, but not significantly.
Revenue vs Market: HCA's revenue (5.2% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: HCA's revenue (5.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HCA's Return on Equity is forecast to be very high in 3 years time (121.2%).
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/31 23:01 |
End of Day Share Price | 2025/01/31 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
HCA Healthcare, Inc. is covered by 46 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jasper Hellweg | Argus Research Company |
Hua Ha | Baird |
Ishan Majumdar | Baptista Research |